France vs Peru: Communicable diseases — Communicable disease incidence
Communicable diseases — Communicable disease incidence over time
- France
- Peru
How they compare
Peru currently reports 1,269 Cases against 453 Cases in France, a difference of 816 Cases.
That makes Peru's figure about 2.8 times France's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was France ahead.
France ranks 9th and Peru ranks 7th of 34 countries.
Peru has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | France | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1,363 Cases | 1,692 Cases | 328.8 Cases | Peru |
| 2010s | 689.9 Cases | 1,647 Cases | 957.2 Cases | Peru |
| 2020s | 501.4 Cases | 1,327 Cases | 825.2 Cases | Peru |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher communicable diseases — communicable disease incidence, France or Peru?
- Peru, at 1,269 Cases against 453 Cases in France as of 2025.
- What is the difference in communicable diseases — communicable disease incidence between France and Peru?
- 816 Cases, with Peru ahead.
- How many years of comparable data are there for France and Peru?
- 25 years are reported by both, from 2000 to 2024.
- How do France and Peru rank globally for communicable diseases — communicable disease incidence?
- France ranks 9th and Peru ranks 7th of 34 countries.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Communicable diseases — Communicable disease incidence. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
This dataset presents time series on Acquired Immunodeficiency Syndrome (AIDS), for the number of AIDS cases and incidence rates per 100 000 population at year of diagnosis. It also includes data on incidence of pertussis, measles, and hepatitis B, in terms of rates of reported cases per 100 000 population. Please refer to the Sources and Methods for detailed country-specific information.